The 50th Annual Meeting of the Society for Cryobiology, CRYO2013, will be held 28-31 July 2013 in the spacious facilities of the North Bethesda Marriott Hotel and Conference Center, just outside Washington, DC.

CRYO2013 is partnering with the International Society for Cellular Therapy (ISCT) for the Symposium Cryopreservation and Good Manufacturing Practice (GMP) – Meeting Industrial and Regulatory Demands.

Dr. Aby J. Mathew, BioLife Solutions, Inc., will be presenting on the topic, Considerations for Development of GMP Biopreservation Solutions for Regenerative Medicine, during the late morning Equipment and Consumables session, Monday July 29th.

Go to Site

The program will highlight the close working relationships between the academic, industry, patient care and regulatory communities. Plenary sessions will include advances in cord blood, updates on CAR-targeted T cells, MSC biology and a timely session on regulatory/accreditation changes. Other planned sessions will cover topics of interest in the areas of technical practice, manufacturing, quality, commercialization and delivery of patient care.

Go to Site

BioLife Solution’s CryoStor CS10® is cited as the cryopreservation reagent in Reduced Engraftment Times using the PremierMaxCB℠ Processing Methodology, Donald Hudspeth, Denise Clifton, and Sara Irrgang, MD – Lifeforce Cryobank Sciences, Inc.; a poster which was presented at The 11th Annual International Cord Blood Symposium, June 6-8, 2013, in San Francisco.

The PremierMaxCB processing methodology replicates previous laboratory and clinical data for the enhanced recovery of desired transplant characteristics from umbilical cord blood samples.

Several DHI physicians reported their beneficial experience with HypoThermosol, including observing less swelling and improved graft viability.

“It’s exciting to see that HypoThermosol, our proprietary, optimized intracellular-like biopreservation medium, is increasingly being adopted by the world’s leading hair transplantation professionals, each committed to improving patient procedure outcomes.” Matt Snyder. ]]> http://biolifesolutions.com/cell-therapy/biopreservation-media/hypothermosol-recognized-as-optimal-hair-graft-solution-at-dhis-2013-academy-masters-meeting/feed/ 0 http://biolifesolutions.com/cell-therapy/biopreservation-media/hypothermosol-articles/hypothermosol-articles-hypothermosol-articles/hypothermosol-storage-of-keratinocytes-for-in-vitro-toxicology/?utm_source=rss&utm_medium=rss&utm_campaign=hypothermosol-storage-of-keratinocytes-for-in-vitro-toxicology http://biolifesolutions.com/cell-therapy/biopreservation-media/hypothermosol-articles/hypothermosol-articles-hypothermosol-articles/hypothermosol-storage-of-keratinocytes-for-in-vitro-toxicology/#comments Fri, 07 Jun 2013 15:59:48 +0000 BioLife Solutions - Blog Manager http://biolifesolutions.com/?p=6294 RRhoads, L. S. Use of hypothermically stored keratinocyte cultures for in vitro toxicology. J Toxicol – Cut. & Ocular. Toxicol. 13(3): 231-48 (1994).

BioLife announced financial results for the first quarter ending March 31, 2013 on May 14th. Revenue set a new quarterly record, besting the previous record of $2.1 million set in Q4 2012. Q1 revenue of $2.2 million was aided by an unusually large contribution in the amount of $609k from licensing. Revenue increased 158% yoy and 6% sequentially. This now marks the 11th consecutive quarter of sequential revenue growth. BLFS was also cash flow positive (ex-changes in working capital) in Q1.
Entire report: Zacks May 16, 2013.

Mike Rice, CEO (right) with BioLife team members: Maile Blair, Sandy Jones, Stacy Holk (Team Captain), Emily Bome, and families.

BioLife Solutions is once again, a proud sponsor of Bothell’s Can Do 5K/10K which benefits Northwest Special Families, an organization dedicated to helping families of children with special needs. Northwest Special Families is part of the Center for Human Services and also partners with the Northshore YMCA to create inclusive and adaptive programming for local area youth.

This year’s event took place on April 27th, under partly sunny skies. It is the third consecutive year that BioLife Solutions has participated in this important community event.

See YouTube presentation:
(If video does not appear please view here: Skills Gap Northshore Schools Foundation).

As a local biotechnology industry partner, BioLife participated in Woodinville High School’s BIO EXPO Symposium where students had the opportunity to investigate careers in biotechnology and develop projects related to the industry. Michael Weaver, Product Development Manager for BioLife, helped judge at this event, while Dr. Aby J. Mathew served as an onsite industry expert. In addition, Dr. Mathew recently addressed the topic of Stem Cells & Regenerative Medicine – The Facts and The Future Potential with a group of Bothell area middle school students at the Environmental Adventure School (EAS).

BioLife is honored to be recognized as a supporter of STEM education and plans to continue to partner with our community to promote science and technology education.

Dr. Aby J. Mathew, Senior Vice President & Chief Technology Officer, BioLife Solutions Inc., will be presenting on the topic: Ensuring the appropriate cryopreservation of your stem cell-based therapy.
May 23, 11:20 AM

World Stem Cells & Regenerative Medicine Congress 2013 is now into its 8th year.
It is Europe’s largest and most senior conference for the stem cell research and regenerative medicine community. 91.9% of 2012 attendees said they would positively recommend this congress to their peers in the industry. Over 65% of attendees come from the industry’s leading pharma, biotech and academic research institutes, with global representation from Europe, North America & Asia.

Go to Site